Cargando…

Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Hernández Pérez, José María, Figueira Gonçálves, Juan Marco, Ramallo Fariña, Yolanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314409/ https://www.ncbi.nlm.nih.gov/pubmed/34336044 http://dx.doi.org/10.5114/aoms/136562

Ejemplares similares

Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients
por: Figueira-Gonçalves, Juan Marco, et al.
Publicado: (2022)

Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency
por: María Hernández Pérez, José, et al.
Publicado: (2022)

SARS-CoV-2 infection in alpha1-antitrypsin deficiency
por: Schneider, Carolin V., et al.
Publicado: (2021)

Biomarkers of acute respiratory distress syndrome in adults hospitalised for severe SARS-CoV-2 infection in Tenerife Island, Spain
por: Figueira Gonçalves, Juan Marco, et al.
Publicado: (2020)

Is the determination of C‐reactive protein really necessary in the diagnosis of Alpha‐1 antitrypsin deficiency?
por: Hernández‐Pérez, José María, et al.
Publicado: (2022)

Is there any kind of relationship between alpha-1 antitrypsin levels and lung function parameters?
por: Hernández-Pérez, José María, et al.
Publicado: (2023)

Prognostic value of lung ultrasound and its link with inflammatory biomarkers in patients with SARS-CoV-2 infection
por: Wangüemert Pérez, A.L., et al.
Publicado: (2021)

Alpha-1 Antitrypsin Deficiency and COVID-19 Infection
por: Strassmair, Michael, et al.
Publicado: (2021)

Description of 22 new alpha-1 antitrypsin genetic variants
por: Renoux, Céline, et al.
Publicado: (2018)

How are we in Brazil with the treatment of alpha-1 antitrypsin deficiency?
por: Castellano, Maria Vera Cruz de Oliveira, et al.
Publicado: (2022)

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection()
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013)

Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2
por: Azouz, Nurit P., et al.
Publicado: (2020)

Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2
por: Azouz, Nurit P., et al.
Publicado: (2021)

Isolated post SARS‑CoV‑2 diplopia
por: dos Santos Martins, Thiago Gonçalves
Publicado: (2020)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden
por: Strålin, Kristoffer, et al.
Publicado: (2021)

Strengths and weaknesses of the diagnostic tests for SARS-CoV-2 infection()
por: Hernández-Pérez, José María, et al.
Publicado: (2020)

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
por: Wettstein, Lukas, et al.
Publicado: (2021)

Clarifying the relationship between pulmonary langerhans cell histiocytosis and Alpha 1 antitrypsin deficiency
por: McCarthy, Cormac, et al.
Publicado: (2021)

SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade
por: Farina, Andrea, et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?
por: Rodríguez-García, Carlota, et al.
Publicado: (2023)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic
por: NORIS-GARCÍA, ELENA, et al.
Publicado: (2022)

Use of oral antiseptics for SARS-CoV-2 infection()
por: Palop Larrea, Vicente, et al.
Publicado: (2020)

False positives in SARS-CoV-2 disease()
por: Pardo-Lledias, Javier, et al.
Publicado: (2021)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

Using Spike Gene Target Failure to Estimate Growth Rate of the Alpha and Omicron Variants of SARS-CoV-2
por: Smith, Benjamin F., et al.
Publicado: (2022)

Systematic reviews and meta-analyses during the SARS-CoV-2 pandemic
por: Ferros, Lucas Sousa Maia, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Myopathy associated with severe SARS-CoV-2 infection
por: Abenza Abildúa, M.J., et al.
Publicado: (2020)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37382bgs39vp338sb77v0uh7ok